CH
COLLINS HELEN LOUISE disclosed sale in Enliven Therapeutics Inc
COLLINS HELEN LOUISE disclosed a sale transaction in Enliven Therapeutics Inc (ELVN) on 2026-05-20.
Action
Sale
Capital
$137,381 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.